The inaugural Spotlight Theme for the 2024 Annual Meeting, as chosen by the new Spotlight subcommittee, is “Precision Health”.

What is Precision Health?
Genes, behaviours, lifestyle (such as exercise and eating habits), and environment are all factors that affect health and performance. Supported by artificial intelligence and/or technology, precision health takes into consideration all of these factors, and can lead to improved individual health or sports performance.

Featuring both in-person and online programming options, the 2024 ACSM Annual Meeting will showcase all the things you’ve come to expect and more, including 200+ hours of sessions, 25+ CECs or CMEs, abstract and clinical cases, exhibit hall, networking opportunities and so much more.

Celebrating its 15th year, the SCOPE Summit stands as a cornerstone in the dynamic landscape of clinical trials and research, pivotal in propelling medical knowledge forward, enhancing patient care, and spearheading the development of innovative treatments and therapies. With over 3,500 attendees representing 850 diverse organisations spanning 27 countries, SCOPE has evolved into a global nexus for experts in clinical operations, trials, innovation, and research.

Activinsights eagerly anticipates the opportunity to spotlight our cutting-edge Clinical data and analytics strategy. Our commitment extends to our pivotal role in shaping Decentralized and Hybrid trials, leveraging digital health technologies, and presenting the compelling real-world evidence we have generated.

Patient-centric health data operators: delivering solutions that empower patients to be in control of their data

Join forces to ensure patient and citizen voices concerning health data are heard.

Shape the vision described in the individual-centric EHDS (European Health Data Space) into Concrete proposals.

CTO and founder Joss Langford will explore the role of personal health data intermediaries in the European Health Data Space (EHDS), amalgamating insights from the MyData Operators and other data space initiatives in his upcoming talk.

The Digital Health Measurement Collaborative Community (DATAcc) by the Digital Medicine Society (DiMe) is excited to launch its core set of digital measures of physical activity!

DATAcc has led a pre-competitive collaboration consisting of patient organisations, biopharmaceutical companies, digital sensor technology companies, and leaders in physical activity to define a core set of digital clinical measures for physical activity that matter to patients across therapeutic areas. By defining these measures and developing practical resources to support their adoption, DATAc has focused the transformational power of innovation and competition on a set of common targets to support quality treatment and care that meet the needs of patients, care providers, industry, and regulators.

DATAc is thrilled to reveal the core digital measures of physical activity and practical resources and hold panel discussions with leaders in the digital measurement and physical activity field, such as Activininsights, CTO, and founder Joss Langford.

The conference will explore the future of clinical research in the UK, building on the Lord O’Shaughnessy Review and the Government’s response. Stakeholders will discuss implementing recommendations to streamline trials, enhance participation, and establish measurable targets. Emphasis will be on innovative approaches to global clinical research leadership and meeting 10-year ambitions amid post-pandemic life sciences recovery. Topics include AI utilisation, data management, workforce development, accessibility, and policy priorities. Sessions cover progress, innovation, and policy direction, with engagement from key policymakers. Keynote speakers include Emma Lowe from DHSC and Activininsights, CTO, and founder Joss Langford.

Join us at the forefront of healthcare innovation at The Power of Digital Biomarkers 2023, where we will explore the limitless potential of digital biomarkers in transforming the future of healthcare.

In a rapidly evolving healthcare landscape, the integration of digital biomarkers has emerged as a revolutionary force, redefining diagnostics, treatment, and patient care.